SEC Filings
Lyell Prices $80.0 Million Stock Sale At $10.77 A Share, Less Than Half March's $25.61
The cell-therapy developer's 10-Q drops a dated cash-runway line as a private placement follows a March tranche priced at $25.61.
LYEL
Lyell Immunopharma (LYEL) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
Lyell's Lymphoma CAR-T Shows 77% Complete Responses, While Quarterly Loss Widens To $45.5 Million
Lyell also raised $80.0 million privately, and says cash now reaches into 2028 as pivotal ronde-cel data approach in mid-2027.
Deals
Lyell Immunopharma Sells $80 Million Of Stock At $10.77 A Share To Fund Ronde-Cel
The CAR T developer's private placement is expected to carry its cash into 2028, with ARCH Venture Partners and RTW Investments among the buyers.